Recombinant Protein Market Share

Statistics for the 2023 & 2024 Recombinant Protein market share, created by Mordor Intelligenceā„¢ Industry Reports. Recombinant Protein share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Recombinant Protein Industry

The recombinant protein market is moderately competitive due to the presence of a few companies operating globally and regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold market shares and are well known, such as Abbvie Inc., Amgen Inc., Bio-Rad Laboratories Inc., Eli Lilly and Company, Merck KGaA, Novo Nordisk AS, Sanofi SA, Thermo Fisher Scientific Inc., Novartis AG, GlaxoSmithKline PLC, Novavax Inc., GigaGen Inc., and Pfizer Inc.

Recombinant Proteins Market Leaders

  1. Eli Lilly and Company

  2. Thermo Fisher Scientific Inc.

  3. Novartis AG

  4. GlaxoSmithKline PLC

  5. Pfizer Inc.

*Disclaimer: Major Players sorted in no particular order

Recombinant Protein Market Concentration

Recombinant Proteins Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)